Affinity DataIC50: 4nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counterMore data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 39nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 54nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 64nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 64nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 65nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 71nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 72nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 81nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 81nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 90nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 91nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 96nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 104nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counterMore data for this Ligand-Target Pair
Affinity DataIC50: 154nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 158nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 164nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 165nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 179nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 180nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 188nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 193nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 267nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 310nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 313nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 313nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 313nMAssay Description:Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counterMore data for this Ligand-Target Pair
Affinity DataIC50: 316nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 345nMAssay Description:Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counterMore data for this Ligand-Target Pair
Affinity DataIC50: 345nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 360nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 408nMAssay Description:Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counterMore data for this Ligand-Target Pair
Affinity DataIC50: 462nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 530nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 589nMAssay Description:Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counterMore data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 671nMAssay Description:Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counterMore data for this Ligand-Target Pair
Affinity DataIC50: 673nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair
Affinity DataIC50: 711nMAssay Description:Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation countingMore data for this Ligand-Target Pair